|
DUSP7 |
dual specificity phosphatase 7 |
- RAF-independent MAPK1/3 activation
- ERKs are inactivated
- Negative regulation of MAPK pathway
- Signaling by MAPK mutants
|
|
|
|
EEF2K |
eukaryotic elongation factor 2 kinase |
- mTORC1-mediated signalling
|
|
|
|
EGFR |
epidermal growth factor receptor |
- Signaling by ERBB2
- Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants
- Signaling by ERBB4
- SHC1 events in ERBB2 signaling
- SHC1 events in ERBB2 signaling
- PLCG1 events in ERBB2 signaling
- PIP3 activates AKT signaling
- Signaling by EGFR
- GRB2 events in EGFR signaling
- GAB1 signalosome
- SHC1 events in EGFR signaling
- EGFR downregulation
- GRB2 events in ERBB2 signaling
- PI3K events in ERBB2 signaling
- EGFR interacts with phospholipase C-gamma
- EGFR Transactivation by Gastrin
- Constitutive Signaling by Aberrant PI3K in Cancer
- Signal transduction by L1
- Constitutive Signaling by EGFRvIII
- Inhibition of Signaling by Overexpressed EGFR
- RAF/MAP kinase cascade
- ERBB2 Regulates Cell Motility
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- ERBB2 Activates PTK6 Signaling
- Cargo recognition for clathrin-mediated endocytosis
- Clathrin-mediated endocytosis
- PTK6 promotes HIF1A stabilization
- Downregulation of ERBB2 signaling
- TFAP2 (AP-2) family regulates transcription of growth factors and their receptors
- Extra-nuclear estrogen signaling
- NOTCH3 Activation and Transmission of Signal to the Nucleus
- HCMV Early Events
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
- Signaling by ERBB2 KD Mutants
- Signaling by ERBB2 ECD mutants
- Signaling by ERBB2 TMD/JMD mutants
- Respiratory syncytial virus (RSV) attachment and entry
- Developmental Lineage of Mammary Gland Myoepithelial Cells
|
- Cetuximab
- Lidocaine
- Gefitinib
- Erlotinib
- Lapatinib
- Panitumumab
- Alvocidib
- IGN311
- Matuzumab
- Vandetanib
- Rindopepimut
- Canertinib
- Pelitinib
- Varlitinib
- AV-412
- S-{3-[(4-ANILINOQUINAZOLIN-6-YL)AMINO]-3-OXOPROPYL}-L-CYSTEINE
- PD-168393
- Afatinib
- Osimertinib
- Necitumumab
- Foreskin keratinocyte (neonatal)
- Depatuxizumab mafodotin
- Icotinib
- Neratinib
- Dacomitinib
- Fostamatinib
- Poziotinib
- Zalutumumab
- Brigatinib
- Olmutinib
- Zanubrutinib
- Abivertinib
- Mobocertinib
- Almonertinib
- Amivantamab
|
- Laryngeal cancer
- Cervical cancer
- Oral cancer
- Gastric cancer
- Choriocarcinoma
- Esophageal cancer
- Glioma
- Bladder cancer
|
|
ELK1 |
ETS transcription factor ELK1 |
- ERK/MAPK targets
- NGF-stimulated transcription
- HCMV Early Events
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
- Estrogen-dependent nuclear events downstream of ESR-membrane signaling
|
|
|
|
ELK3 |
ETS transcription factor ELK3 |
|
|
|
|
ELK4 |
ETS transcription factor ELK4 |
|
|
|
|
ELP1 |
elongator acetyltransferase complex subunit 1 |
|
|
|
|
EP300 |
EP300 lysine acetyltransferase |
- Regulation of gene expression by Hypoxia-inducible Factor
- Polo-like kinase mediated events
- Pre-NOTCH Transcription and Translation
- Pre-NOTCH Transcription and Translation
- PPARA activates gene expression
- PPARA activates gene expression
- Formation of the beta-catenin:TCF transactivating complex
- Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells
- NOTCH1 Intracellular Domain Regulates Transcription
- NOTCH1 Intracellular Domain Regulates Transcription
- SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription
- NOTCH2 intracellular domain regulates transcription
- Constitutive Signaling by NOTCH1 PEST Domain Mutants
- Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants
- LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production
- HATs acetylate histones
- Attenuation phase
- Transcriptional regulation of white adipocyte differentiation
- Transcriptional regulation of white adipocyte differentiation
- SUMOylation of transcription cofactors
- B-WICH complex positively regulates rRNA expression
- Activation of anterior HOX genes in hindbrain development during early embryogenesis
- CD209 (DC-SIGN) signaling
- Metalloprotease DUBs
- TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
- Regulation of TP53 Activity through Acetylation
- Regulation of TP53 Activity through Methylation
- PI5P Regulates TP53 Acetylation
- Activation of the TFAP2 (AP-2) family of transcription factors
- RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function
- RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known
- RUNX3 regulates NOTCH signaling
- RUNX3 regulates NOTCH signaling
- Regulation of RUNX3 expression and activity
- RUNX3 regulates p14-ARF
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH3 Intracellular Domain Regulates Transcription
- NOTCH4 Intracellular Domain Regulates Transcription
- Estrogen-dependent gene expression
- NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux
- NGF-stimulated transcription
- NGF-stimulated transcription
- TRAF3-dependent IRF activation pathway
- TRAF6 mediated IRF7 activation
- FOXO-mediated transcription of cell death genes
- Transcriptional regulation of granulopoiesis
- Transcriptional regulation of granulopoiesis
- Regulation of FOXO transcriptional activity by acetylation
- Regulation of FOXO transcriptional activity by acetylation
- STAT3 nuclear events downstream of ALK signaling
- Heme signaling
- SARS-CoV-1 targets host intracellular signalling and regulatory pathways
- Nuclear events mediated by NFE2L2
- Formation of paraxial mesoderm
- NFE2L2 regulating inflammation associated genes
- NFE2L2 regulating anti-oxidant/detoxification enzymes
- NFE2L2 regulates pentose phosphate pathway genes
- NFE2L2 regulating tumorigenic genes
- NFE2L2 regulating MDR associated enzymes
- NFE2L2 regulating ER-stress associated genes
- Regulation of NFE2L2 gene expression
- Regulation of NFE2L2 gene expression
- Zygotic genome activation (ZGA)
- Evasion by RSV of host interferon responses
- TGFBR3 expression
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesis and hepatic steatosis
- Transcriptional and post-translational regulation of MITF-M expression and activity
- Transcriptional and post-translational regulation of MITF-M expression and activity
- Regulation of PD-L1(CD274) transcription
- Expression of BMAL (ARNTL), CLOCK, and NPAS2
- RORA,B,C and NR1D1 (REV-ERBA) regulate gene expression
|
|
- Rubinstein-Taybi syndrome
|
|
ETV1 |
ETS variant transcription factor 1 |
|
|
- Prostate cancer
- Ewing's sarcoma
|
|
FAM193B |
family with sequence similarity 193 member B |
|
|
|
|
FZR1 |
fizzy and cell division cycle 20 related 1 |
- Autodegradation of Cdh1 by Cdh1:APC/C
- SCF-beta-TrCP mediated degradation of Emi1
- APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
- Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase
- Regulation of APC/C activators between G1/S and early anaphase
- Phosphorylation of Emi1
- Senescence-Associated Secretory Phenotype (SASP)
- Assembly of the pre-replicative complex
- CDK-mediated phosphorylation and removal of Cdc6
- Cyclin A/B1/B2 associated events during G2/M transition
- Cyclin A:Cdk2-associated events at S phase entry
- Transcriptional Regulation by VENTX
- Aberrant regulation of mitotic exit in cancer due to RB1 defects
- Antigen processing: Ubiquitination & Proteasome degradation
|
|
|
|
GANAB |
glucosidase II alpha subunit |
- N-glycan trimming in the ER and Calnexin/Calreticulin cycle
- Calnexin/calreticulin cycle
- Maturation of spike protein
- Maturation of spike protein
- Regulation of CDH1 posttranslational processing and trafficking to plasma membrane
|
|
|
|
GARS1 |
glycyl-tRNA synthetase 1 |
- Cytosolic tRNA aminoacylation
- Mitochondrial tRNA aminoacylation
|
|
- Charcot-Marie-Tooth disease (CMT); Hereditary motor and sensory neuropathy; Peroneal muscular atrophy
- Distal hereditary motor neuropathies (dHMN)
|
|
GDF10 |
growth differentiation factor 10 |
|
|
|
|
GEMIN5 |
gem nuclear organelle associated protein 5 |
- snRNP Assembly
- SARS-CoV-2 modulates host translation machinery
|
|
|
|
GFPT1 |
glutamine--fructose-6-phosphate transaminase 1 |
- XBP1(S) activates chaperone genes
- Defective GFPT1 causes CMSTA1
- Synthesis of UDP-N-acetyl-glucosamine
|
|
|
|
GORASP2 |
golgi reassembly stacking protein 2 |
- Golgi Cisternae Pericentriolar Stack Reorganization
|
|
|
|
GPRIN2 |
G protein regulated inducer of neurite outgrowth 2 |
|
|
|
|
GSTP1 |
glutathione S-transferase pi 1 |
- Glutathione conjugation
- Detoxification of Reactive Oxygen Species
- Neutrophil degranulation
- Paracetamol ADME
|
- Glutathione
- Troglitazone
- Clozapine
- Etacrynic acid
- Clomipramine
- (9R,10R)-9-(S-glutathionyl)-10-hydroxy-9,10-dihydrophenanthrene
- S-Hydroxycysteine
- Cibacron Blue
- Glutathione sulfonic acid
- Glutathione disulfide
- Deoxycholic acid
- Deoxycholic acid
- S-(4-nitrobenzyl)glutathione
- 2-(N-morpholino)ethanesulfonic acid
- S-Hexylglutathione
- Canfosfamide
- Ezatiostat
- Exisulind
- S-NONYL-CYSTEINE
- S-(4-BROMOBENZYL)CYSTEINE
- Curcumin
- Dinitrochlorobenzene
- Hypericin
- Curcumin sulfate
|
|
|
GUCY1A1 |
guanylate cyclase 1 soluble subunit alpha 1 |
- Nitric oxide stimulates guanylate cyclase
- Smooth Muscle Contraction
- Smooth Muscle Contraction
|
|
|